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Dear	  Dr.	  Reinbolt,	  Dr.	  Hamel,	  and	  Mr.	  Wheelock,	  
	  
First	   and	   foremost,	   Volunteer	   Medical	   Technologies	   would	   like	   to	   thank	   you	   for	  
serving	   as	   our	   stakeholders	   for	   the	   duration	   of	   the	   project.	   Your	   guidance	   and	  
advice	   regarding	   team	  management	   was	   instrumental	   in	   the	   success	   of	   our	   final	  
design.	  	  
	  
This	  report	  outlines	  all	  of	  the	  steps	  that	  were	  taken	  in	  order	  to	  complete	  the	  design	  
process	   for	   our	   infant	   sleep	   apnea	   device	   and	   produce	   a	   functional	   prototype.	   As	  
you’ll	  see,	  all	  phases	  of	  the	  design	  process	  will	  be	  discussed	  in	  depth.	  The	  report	  also	  
contains	  an	  objective	  evaluation	  of	  our	  design.	  	  
	  
Upon	   looking	   over	   the	   report,	   we	   ask	   that	   you	   give	   your	   feedback	   on	   our	   final	  
product	  as	  well	  as	  the	  individual	  components	  of	  our	  design	  process.	  	  Any	  feedback,	  
whether	   positive	   or	   negative,	  would	   be	   greatly	   appreciated.	   Also,	   if	   you	   have	   any	  
questions	  regarding	  our	  design,	  please	  feel	  free	  to	  contact	  our	  team	  leader,	  Trevor	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   Volunteer	  Medical	  Technologies	  (VMT)	  designed	  a	  device	  that	  can	  be	  used	  in	  
the	   treatment	   of	   central	   sleep	   apnea	   in	   infants.	   The	   assessed	   needs	   of	   the	  
stakeholders	  stated	  that	  the	  device	  must	  be	  able	  to	  accurately	  detect	  an	  episode	  of	  
apnea,	   provide	   a	   stimulus	   that	   will	   correct	   the	   apnea,	   and	   sound	   an	   alarm	   if	   the	  
stimulus	  does	  not	  restore	  a	  normal	  breathing	  pattern.	  	  
	   The	  final	  design	  consists	  of	  a	  pulse	  oximeter,	  RIPmate	  thorax	  inductance	  kit,	  
a	   solid-­‐state	   relay,	   and	  a	  belt	  with	  vibrating	  motors.	  During	  concept	  development,	  
however,	  several	  alternatives	  were	  considered.	  Some	  of	   the	  alternatives	   that	  were	  
considered	   included	  thermistors	  as	  a	  monitoring	  mechanism,	  a	  servo	  controller	   to	  
be	  used	   to	   transfer	   the	   signal	   from	   the	  computer	   to	   the	   stimulus	  hardware,	   and	  a	  
motion	  bed	  or	  audio	  as	  our	  stimulus.	  Upon	  evaluation	  of	  all	  of	   the	  considerations,	  
VMT	  settled	  on	  the	  components	  that	  were	  used	  for	  the	  final	  design	  for	  a	  number	  of	  
reasons.	   The	   monitoring	   devices,	   the	   pulse	   oximeter	   and	   the	   RIPmate	   belt	   were	  
chosen	   because	   they	   are	   the	   best	   indicators	   of	   an	   apnea	   episode.	   Two	   different	  
biosignals	  were	  monitored	  in	  order	  to	  be	  in	  compliance	  with	  the	  American	  Society	  
of	  Sleep	  Medicine	  (ASSM).	  The	  solid-­‐state	  relay	  was	  chosen	  because	  of	  the	  simplicity	  
of	   the	  design.	  The	  vibrating	  motors	  were	  chosen	  as	   the	  stimulus	  because	   they	  are	  
effective	   and	   can	  be	   easily	  manipulated	   to	   avoid	   the	  patient	  becoming	   immune	   to	  
them.	  	  
	   After	   construction,	   the	   device	   was	   tested	   multiple	   times.	   First,	   each	  
individual	  component	  was	  tested	  to	  ensure	  proper	  functioning.	  Next,	  the	  integrated	  
system	  was	  tested.	  The	  tests	  consisted	  of	  members	  of	  VMT	  wearing	  the	  device	  and	  
holding	   their	   breath	   for	   a	   period	   of	   10	   seconds	   or	   until	   there	   was	   a	   3%	   drop	   in	  
oxygen	   saturation.	   In	   the	   properly	   functioning	   device,	   these	   events	  would	   trigger	  
the	   vibrating	   motors	   to	   turn	   on	   and	   if	   the	   normal	   breathing	   pattern	   was	   not	  
restored	  within	  5	  seconds,	  the	  alarm	  sounded.	  	  
	   This	   device	   is	   currently	   the	   only	   product	   that	   incorporates	   both	   detection	  
and	  stimulation	  into	  one	  device.	  This	  notion	  is	  very	  innovative	  and	  can	  prove	  to	  be	  
very	   lucrative	   in	   the	   future.	   It	   can	   also	   lead	   to	  more	   groundbreaking	   devices	   and	  




There	  are	  three	  types	  of	  sleep	  apnea	  –	  central	  sleep	  apnea,	  obstructive	  sleep	  
apnea,	  and	  mixed	  sleep	  apnea.	  Central	  sleep	  apnea	  involves	  a	  brain	  deficiency	  that	  
leads	   to	   successions	  of	  breathing.	  Obstructive	   apnea	   is	   a	   result	   of	  physical	   airway	  
blockage	  and	  mixed	  sleep	  apnea	  is	  a	  combination	  of	  central	  and	  obstructive	  apnea	  
[3].	   An	   apnea	   episode	   is	   defined	   by	   10-­‐20	   seconds	   without	   breathing	   [6].	   Apnea	  
home	  monitoring	  systems	  are	  prescribed	  to	  infants	  who	  have	  prolonged	  episodes	  of	  
apnea	   and/or	   bradycardia	   resulting	   from	   prematurity	   [2,8].	   	   Home	   monitors	   are	  
also	   prescribed	   to	   infants	   who	   are	   direct	   siblings	   of	   SIDS	   victims	   [2,8].	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Contemporary	   monitors	   record	   respiratory	   and	   cardiac	   data	   using	   leads	   on	   the	  
heart	   held	   in	   place	   by	   a	   Velcro	   belt	   or	   adhesive	   strip	   [8].	   The	   monitors	   have	  
adjustable	  sensitivity	  and	  they	  sound	  an	  alarm	  for	  the	  caregiver	  when	  intervention	  
is	   necessary	   [8].	   Intervention	   involves	   simple	   physical	   stimulation	   via	   a	   sternum	  
rub.	  In	  extreme	  cases	  cardio-­‐pulmonary	  resuscitation	  may	  be	  required	  [8].	  
The	  need	   for	  a	  device	   that	  accurately	  detects	  apnea	  episodes,	  and	  provides	  
an	  automated	  stimulus	  to	  restore	  natural	  breathing	  patterns	  has	  been	  proposed	  by	  
the	  University	  of	  Tennessee	  Graduate	  School	  of	  Medicine.	  It	   is	  believed	  that	  such	  a	  
device	  will	  aid	  infants	  and	  caregivers	  in	  a	  positive	  manner	  with	  respect	  to	  improved	  
sleep	  architecture	  and	  soundness	  of	  mind.	  Furthermore,	  a	  device	  of	  this	  nature	  will	  
reduce	   the	   amount	  of	   parental	   intervention	  during	   sleep	   cycles.	  This	  device	  has	   a	  
large	   market,	   and	   the	   opportunities	   of	   this	   device	   are	   multifaceted.	   A	   successful	  
design	  can	  lead	  to	  both	  improved	  infant	  sleep	  patterns	  as	  well	  financial	  gains.	  	  
Upon	   analyzing	   the	   competitive	   technologies,	   VMT	   found	   that	   there	   are	   no	  
devices	  that	  seek	  to	  aid	  central	  sleep	  apnea	  in	  infants	  by	  automated	  stimulation.	  As	  
previously	   stated	   the	   only	   technology	   for	   infants	   is	   a	   monitor	   system	   that	  
incorporates	   an	   alarm	   for	   notification	   of	   necessary	   parental	   intervention.	   One	  
notable	  claim	  was	  found	  while	  researching	  Adaptive	  Servo-­‐Ventilation	  systems.	  This	  
system	  claims	  to	  correct	  apnea	  episodes	  of	  multiple	  natures.	  The	  system	  accurately	  
detects	  and	  corrects	  both	  obstructive	  and	  central	  sleep	  apnea	  in	  adults	  by	  detecting	  
the	   patient’s	   need	   to	   breathe	   and	   administering	   pressure	   when	   necessary	   via	   a	  
respiratory	  mask	  [12,13].	  Many	  technologies,	   including	  continuous	  positive	  airway	  
pressure	   (CPAP)	   and	   expository	   positive	   airway	   pressure	   (EPAP),	   seek	   to	   correct	  
obstructive	   apnea	   because	   of	   its	   growing	   appearance	   in	   the	   adult	   population.	  
Obstructive	   apnea	   is	   especially	   prevalent	   in	   obese	   adults.	   VMT	   researched	   the	  
methods	  of	   correcting	  obstructive	  apnea	   to	   see	   if	   any	  useful	   information	   could	  be	  
applied	  to	  the	  proposed	  device.	  Unfortunately,	  these	  technologies	  focus	  primarily	  on	  
opening	   the	   airway	   via	   multiple	   methods.	   This	   is	   not	   applicable	   to	   central	   sleep	  
apnea	  in	  infants,	  because	  the	  issue	  does	  not	  involve	  a	  blockage	  of	  airway,	  but	  rather	  
a	  brain	  deficiency	  with	  respect	  to	  breathing.	  	  
A	  notable	  technology	  that	  has	  been	  tested	  on	  infants	  in	  the	  past	  is	  the	  use	  of	  
rhythmic	  waterbeds.	  Reduction	  of	  Sleep	  Apnea	  and	  Bradycardia	  in	  Preterm	  Infants	  on	  
Oscillating	  Water	  Beds:	  A	  Controlled	  Polygraphic	  Study	  by	  Korner	  et	  al.	   investigated	  
the	  effects	  of	  vestibular-­‐proprioceptive	  stimulation	  on	  early	  development.	  The	  setup	  
involved	  infants	  sleeping	  on	  a	  waterbed	  that	  involved	  periodic	  wave	  movement.	  One	  
of	  the	  most	  striking	  developments	  of	  this	  study	  was	  that	  infants	  in	  the	  experimental	  
group	   experienced	   a	   marked	   reduction	   in	   sleep	   apnea	   occurring	   during	   sleep.	  	  
Instances	  of	  apnea	  of	  prolonged	  length	  (10	  seconds	  or	  longer)	  were	  reduced	  more	  
when	  on	   the	  waterbed,	   suggesting	   that	   regular	  periodic	  movement	  plays	  a	   critical	  
role	  in	  patients	  who	  suffer	  from	  central	  sleep	  apnea	  [7].	  Although	  this	  method	  was	  
successful	  in	  reducing	  the	  quantity	  of	  apnea	  episodes	  experienced,	  it	  does	  not	  seek	  
to	  correct	  the	  apnea	  episodes	  that	  do	  occur.	  Furthermore,	  this	  rhythmic	  method	  can	  
lull	  the	  infant	  into	  deeper	  sleep	  making	  it	  less	  likely	  for	  them	  to	  be	  aroused	  out	  of	  an	  
apnea	  episode	  without	  intervention.	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Problem	  Definition	  
	  
The	   overall	   purpose	   in	   designing	   this	   device	   is	   to	   allow	   a	   patient	   suffering	  
from	   sleep	   apnea	   to	   have	   the	   condition	   accurately	   detected,	   and	   once	   detected,	  
disrupt	   the	   apnea	   episode	   in	   order	   to	   assist	   the	   patient	   in	   returning	   to	   a	   normal	  
pattern	   of	   sleep.	   The	   nature	   of	   this	   project	   has	   consisted	   of	   gaining	   a	   basic	  
understanding	  of	  what	   is	   required	   to	  successfully	   follow	   through	  with	   the	  project,	  
notably	   by	   determining	   the	   required	   specifications	   and	   assessing	   the	   costs	  
associated	  with	  them.	  
After	  meeting	  with	   stakeholders	   and	   reviewing	   the	   needs	   for	   sleep	   apnea,	  
VMT	  planned	  a	  new	  home	  device	  to	  aid	  in	  sleep	  apnea.	  This	  device	  should	  accurately	  
detect	   and	   monitor	   sleep	   apnea	   in	   a	   patient	   at	   home.	   Once	   an	   apnea	   episode	   is	  
detected,	   the	   device	   should	   issue	   a	   stimulus	   to	   disrupt	   the	   patient’s	   irregular	  
sleeping	  pattern.	  The	  device	  should	  be	  capable	  of	  producing	  a	  random	  stimulation	  
when	   certain	   criteria	   are	   met	   in	   order	   to	   disrupt	   the	   apnea	   episode.	   The	   device	  
should	  also	  be	  capable	  of	  gradually	  increasing	  the	  intensity	  of	  stimulation	  if	  there	  is	  
no	  response	  from	  the	  patient.	  In	  the	  event	  that	  a	  patient’s	  breathing	  is	  not	  restored	  
by	  the	  random	  stimulus,	  this	  device	  should	  be	  able	  to	  alert	  a	  caregiver.	  The	  device	  
will	  need	  an	  adjustable	  sensitivity.	  The	  device	  should	  be	  comfortable,	  portable,	  and	  
easily	  put	  on	  and	  taken	  off.	  
The	   ultimate	   function	   of	   this	   product	   is	   to	  monitor	   the	   breathing	   of	   infant	  
patients	  who	  suffer	  from	  central	  sleep	  apnea.	  It	  needs	  to	  perform	  the	  following	  tasks	  
to	  accurately	  detect	  and	  stimulate	  any	  patient	  suffering	  from	  sleep	  apnea:	  accurately	  
monitor	   apnea,	   issue	   a	   stimulus	   once	   an	   apnea	   episode	   is	   detected,	   and	   alert	   any	  
caregivers	   if	   stimulus	   is	   ineffective.	   This	   device	   should	   be	   able	   to	   calibrate	  
accordingly	  to	  each	  patient’s	  sensitivity	  to	  the	  stimulus,	  as	  well	  as,	  be	  comfortable,	  
portable,	   and	   easily	   applied.	   This	   device	   should	   accurately	   detect	   life	   threatening	  
sleep	  apnea	  episodes	  with	  a	  respiratory	  inductance	  plethysmography	  (RIP)	  belt	  and	  
pulse	   oximeter	   in	   order	   to	   comply	   with	   the	   AASM.	   The	   device	   should	   be	   able	  
perform	   the	   previous	   stated	   tasks	  with	  minimal	   error	   and	   in	   real	   time.	   Detection	  
and	  stimulation	  via	  the	  RIP	  belt,	  pulse	  oximeter,	  and	  stimulation	  mechanism	  will	  be	  
the	  most	  vital	  requirements	  for	  this	  device.	  	  
The	   primary	   data	   elements	   of	   this	   system	   will	   be	   real-­‐time,	   analyzed	  
physiological	  signals	  from	  the	  patient.	  These	  monitored	  biosignals	  consist	  of	  oxygen	  
saturation	   of	   hemoglobin,	   and	   the	   respiratory	   pattern.	   The	   data	   for	   each	   of	   these	  
signals	  will	  be	  obtained	  via	  a	  pulse	  oximeter	  and	  a	  RIP	  belt	  respectively.	  The	  control	  
system	   algorithm	   will	   analyze	   the	   real	   time	   biosignals	   from	   the	   monitors	   and	  
deduce	  the	  appropriate	  measures	  to	  take	  going	  forward.	  	  If	  the	  data	  signals	  suggest	  
an	  apnea	  episode	  is	  occurring	  (>3%	  drop	  O2	  and	  cessation	  of	  breathing	  for	  >15	  sec)	  
the	  controller	  will	  then	  signal	  the	  vibration	  mechanisms	  to	  start	  vibrating	  [3].	  If	  the	  
stimulation	  is	  unsuccessful	  the	  control	  system	  will	  activate	  an	  alert	  mechanism.	  The	  
thresholds	  for	  the	  alert	  can	  be	  modified	  by	  the	  user,	  as	  some	  caregivers	  would	  like	  
to	  know	  when	  every	  apnea	  episode	  is	  occurring	  and	  not	  just	  the	  prolonged	  episodes.	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The	  functions	  and	  requirements	  for	  this	  prototype	  are	  again	  stated	  below:	  
• RIP	  belt	  should	  fit	  securely,	  but	  comfortably	  around	  patient	  
• Pulse	  oximeter	  should	  connect	  to	  patient	  directly	  via	  finger	  
• Biosignals	  should	  be	  gathered	  and	  processed	  with	  a	  computer	  algorithm	  
• Stimulants	  will	  consist	  of	  small	  vibrators	  that	  are	   incorporated	  into	  the	  RIP	  
belt	  and	  automatically	  triggered	  based	  on	  biosignals.	  
• An	  alarm	  should	  be	  attached	  to	  the	  device	  for	  patients	  in	  need	  of	  immediate	  
attention	  from	  a	  caregiver	  if	  stimulation	  is	  not	  adequate.	  	  
	  
The	   primary	   constraints	   of	   this	   device	   will	   be	   FDA	   regulations.	   The	   FDA	   is	  
particularly	   stringent	   on	   devices	   that	   come	   into	   direct	   contact	   with	   patients,	  
especially	  infants.	  As	  the	  design	  process	  proceeds	  particular	  attention	  will	  be	  paid	  to	  
FDA	   regulations	   to	   ensure	   a	   functional,	   producible,	   profitable	   device	   can	   be	  
manufactured	   for	   wide	   scale	   use.	   Another	   constraint	   will	   be	   adherence	   to	   the	  
AASM’s	   diagnostic	   factors	   of	   central	   apnea	   episodes	   in	   infant	   patients.	   Societal	  
expectations	  will	  also	  be	  considered	  heavily	  in	  the	  proposed	  design	  because	  of	  the	  
patient	  demographic	  and	  the	  setting	   in	  which	  the	  device	  will	  be	  used.	  Parents	  will	  
expect	   the	  device	   to	  have	  minimal	   to	  no	  safety	  hazards	  because	   the	  device	  will	  be	  




The eventual objective of this design project was to create a prototype that 
monitors the sleeping patterns of infants, specifically, at risk infants suffering from sleep 
apnea. The device originally focused on infants within a hospital setting; however, the 
group felt the device could also be suited for home use as well. Before reaching the final 
product of the device, the VMT had to perform extensive research and consider concepts 
to eventually reach a design that felt suitable to create. 
In particular, the team felt it was important to investigate two aspects that would 
make the device perform to its maximum potential. First, would be components that 
would promote a high level of efficiency for the device, and secondly, making sure 
proper safety precautions are accounted for, given the target group of the device. 
In terms of efficient components, since the primary function of the device was to 
monitor apnea, the team needed to consider a proper monitor that would best fit the 
device as well as the resources provided. Examples of common monitoring instruments 
include thermistors, pressure transducers, electroencephalogram (EEG), audio, RIP belts 
and pulse oximeters. Out of these six types of monitoring instruments the team decided to 
incorporate two: a RIP belt, and a pulse oximeters.  
The team felt that thermistors and pressure transducers would not tailor to their 
needs because these instruments collect data in the facial region. VMT decided that the 
device needed to be as comfortable as possible and thus sought to avoid any instruments 
gathering data at or near the face. EEGs were ruled out for the same reason. VMT felt 
that monitoring audio would be subject to noise and thus inaccuracies in detection of 
apnea.  
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Next, is accounting for safety. Since the team decided to use a stimulating method 
to alarm the patient and caregiver in case of emergency, the team had to account for the 
intensity of an alarm. A method the team agreed absolutely not to use by any means was 
electrical shock. Electrical shock could place the patient in unnecessary harm, interfering 
with the monitoring of data. Additionally, since the target group for this design was 
infants, it would be extremely unethical to apply electrical shock on a fragile infant, 
which may result in possible lawsuits for damages. In summary, these concepts are taken 
into account, so that the team would approach a suitable method to create its intended 
device. 
 To further elaborate on the concept of the design, the team needed to investigate 
approaches that would help its quality and allow it to stand out as an apnea device. 
Specifically, the team investigated obtaining bio-signals of blood oxygen saturation. 
Given that a pulse oximeter represents a device that monitors blood oxygen saturation, 
the team investigated the type of pulse oximeter that would be efficient, but also adhered 
to a non-invasive method. Ultimately, these considerations lead to the decision to use a 
transmission based pulse oximetry method. This method would simply involve the patient 
to have his or her blood measured by a monitoring device that goes on the finger. 
Because the team definition of non- invasive meant anywhere below the neck, using the 
transmission based pulse oximetry felt like the best choice in terms of reliability as well 
as compliance with a non-invasive approach. 
 Another method acknowledged was a motion bed. This option would serve as a 
stimulant mechanism for patients in the middle of an apnea episode. Although a 
seemingly dependable resource, the team felt it was not ideal for this project for two main 
reasons. First, if an infant were to use this bed, he or she may adapt to the comfort of the 
bed and may not respond to the stimulus applied. Secondly, since motion beds could be 
used by infants, the cost of these beds could be much higher than the price of a crib, 
which may discourage parents and caregivers from purchasing it for the infant. This is 
why the team felt it would not be the best method to use for the design project. 
 With the extensive amount of information Volunteer Medical Technologies 
researched from the deliverable assignments, the team had to use the information it 
learned in order to create guidelines concerning the design process. An important concept 
the team deduced from its research was creating a device that was silent, portable and 
easy to use. In particular, after researching about EPAP (Expository Positive Airway 
Pressure) devices produced by a company known as Provent, the team was able to gain 
that concept and attempt to apply it to the design project. In contrast, one of the major 
concepts considered out of the entire project was to make the design approach non-
invasive.  
A further step, which was determined, based on the decision of the group was to 
define non-invasive as any contact between the device and patient that is below the neck. 
This was a foundation for the project because much of the research and considerations 
made toward constructing the design primarily depended on whether the design was non-
invasive or not. 
 One way that team members could understand the concepts considered and design 
approach simultaneously was by figures. Shown below as Figure 1, is the Traceability 
Matrix which inspected function requirements for the design. Shown in Figure 2, is the 
Quad Chart which details the design approach of the team. 
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Fig 1. Traceability Matrix A functional requirements outline and guide on how the 
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Fig. 2 Quad Chart Preliminary design approach that would be taken in order to plan and 
develop the prototype. 
 
Product	  Description	  
This	  prototype	  consists	  of	  four	  main	  components.	  The	  prototype	  first	  collects	  
the	  necessary	  biosignals,	  and	  then	  processes	  the	  biosignals	  using	  specific	  thresholds	  
for	   each	   signal	   respectively.	   The	   threshold	   comparison	   is	   used	   to	   trigger	   the	  
stimulus,	   and	   the	   amount	   of	   time	   that	   the	   stimulus	   is	   active	   is	   monitored.	   If	   the	  
stimulus	   is	   unsuccessful	   in	   restoring	   natural	   breathing	   patterns,	   then	   an	   audible	  
alert	  mechanism	   is	   activated.	   The	  majority	   of	   this	  was	   accomplished	   through	   the	  
integration	  of	  multiple	  algorithms	  in	  LabVIEW	  (National	  Instruments).	  The	  control	  
diagram	  for	  this	  prototype	  can	  be	  found	  below	  in	  Figure	  3.	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Fig.	  3	  Control	  System	  This	  system	  consists	  of	  four	  main	  parts:	  gathering	  biosignals,	  
processing	  biosignals,	  a	  stimulus	  mechanism,	  and	  an	  audible	  alert	  mechanism.	  	  
	  
The	  first	  algorithm	  consisted	  of	  gathering	  the	  data	  from	  the	  Ambu	  RIPmate	  belt.	  The	  
RIPmate	   belt	   outputs	   a	   voltage	   signal	   in	   the	   mV	   range.	   Using	   LabVIEW	   in	  
conjunction	  with	   the	  Measurement	  Computing	  1208FS	  A/D	   converter,	   the	   voltage	  
signal	  was	  continuously	  streamed	  into	  the	  system.	  The	  raw	  data	  signal	  was	  filtered	  
in	  LabVIEW	  using	  a	   low	  pass	  filter	  with	  a	  cutoff	   frequency	  of	  0.16	  Hz.	  A	  sample	  of	  
the	  raw	  signal	  and	  the	  respective	  filtered	  signal	  can	  be	  found	  below	  in	  Figure	  4.	  This	  
specific	  cutoff	  frequency	  was	  recommended	  by	  Ambu	  in	  the	  technical	  specifications	  
for	   the	   belt.	   The	   filtered	   signal	   was	   analyzed	   with	   respect	   to	   its	   amplitude.	   	   The	  
amplitude	   of	   the	   respiratory	   signal	   was	   constantly	   monitored	   for	   “flat-­‐line”	  
characteristics.	   Based	   on	   the	   ASSM	   guidelines,	   a	   period	   of	   15	   seconds	   without	  
breathing	   is	   considered	  an	  apnea	  episode.	   	  When	   the	   respiratory	   signal	   started	   to	  
flat-­‐line,	   a	   clock	  was	   started.	   For	   this	  program,	   the	   signal	  was	   considered	   flat-­‐line	  
when	   the	   amplitude	  was	   less	   than	   or	   equal	   to	   1nV.	   The	   clock	   reset	   to	   zero	  when	  
acceptable	  amplitude	  was	  measured.	  If	  the	  signal	  remained	  at	  flat-­‐line	  for	  more	  than	  
15	  seconds,	  the	  stimulus	  was	  triggered.	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Fig.	  4	  Respiratory	  Signal	  The	  raw	  respiratory	  signal	  shown	  on	  top	  was	  filtered	  
using	  a	  low	  pass	  filter	  with	  a	  cutoff	  frequency	  of	  0.16	  Hz	  to	  produce	  the	  smooth	  
signal	  shown	  on	  the	  bottom.	  	  
	  
The	  second	  algorithm	   involved	  processing	  pulse	  oximeter	  data.	  The	  NONIN	  
8500m	  pulse	  oximeter	  was	  used	  in	  conjunction	  with	  the	  NONIN	  1000	  USB	  adapter	  
to	  stream	  serial	  data	   into	   the	  computer.	  LabVIEW	  read	   the	  serial	  packet	   in	  COM6,	  
which	  consisted	  of	   the	   logical	  data.	  This	  data	   included	  both	  oxygen	  saturation	  and	  
heart	  rate	  data.	  An	  open	  source	  LabVIEW	  code	  was	  used	  to	  continuously	  stream	  the	  
logical	   data	   into	   a	   display	   window	   on	   the	   computer.	   VMT	   continued	   with	   the	  
programming	  by	  separating	  the	  O2	  data	  from	  the	  heart	  rate	  data.	  Once	  separated	  the	  
data	   was	   converted	   from	   string	   to	   numerical	   format	   so	   that	   it	   could	   be	   used	   in	  
numerical	   threshold	   comparisons.	   Once	   the	   program	   was	   streaming	   meaningful	  
data,	  the	  program	  would	  collect	  data	  for	  the	  calculation	  of	  the	  reference	  saturation.	  
This	  was	  accomplished	  by	  building	  an	  array	  of	  saturation	  data.	  Once	  the	  array	  was	  
filled	  with	   the	  desired	  number	  of	  data	  points,	   the	  array	  was.	  The	  size	  of	   the	  array	  
was	   programmed	   as	   a	   control;	   for	   demonstration	   purposes	   it	   was	   set	   to	   10.	   The	  
average	  of	  this	  saturation	  array	  was	  stored	  as	  the	  reference	  saturation	  and	  could	  be	  
recalculated	   during	   any	   time	  while	   the	   program	  was	   running.	   Once	   the	   reference	  
saturation	  was	  in	  hand,	  the	  program	  proceeded	  by	  comparing	  each	  new	  data	  point	  
to	  the	  reference.	  Based	  on	  the	  ASSM	  guidelines,	  a	  3%	  drop	  in	  oxygen	  saturation	  is	  
considered	   an	   apnea	   episode.	   The	   algorithm	   was	   programmed	   such	   that	   if	   the	  
difference	  between	  the	  current	  saturation	  and	  the	  reference	  was	  greater	  than	  3	  the	  
stimulus	  was	  triggered.	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The	  third	  component	  of	  this	  prototype	  is	  the	  stimulus	  algorithm	  along	  with	  
its	  manufacturing.	  VMT	  decided	  to	  use	  VPM2	  Vibrating	  Disk	  Motors	  for	  the	  stimulus.	  
These	   particular	   disks	   operate	   at	   a	   voltage	   of	   3V.	   The	   vibrating	   disks’	   leads	   are	  
soldered	   together	   in	   series	   and	   three	   9V	   batteries	   are	   connected	   in	   series.	   These	  
batteries	  supply	  a	  total	  of	  27V	  to	  the	  9	  vibrating	  disks,	  which	  effectively	  distributes	  
3V	  to	  each	  disk.	  The	  disks	  are	  attached	  with	  an	  adhesive	  to	  the	  stimulus	  belt.	  This	  
belt	  is	  simply	  an	  elastic	  band	  with	  Velcro	  that	  wraps	  around	  the	  patient	  torso.	  The	  
battery	   pack	   is	   connected	   to	   a	   solid-­‐state	   relay	   (NTE	   Electronics)	   that	   acts	   as	   a	  
switch.	   When	   supplied	   with	   the	   proper	   voltage	   the	   switch	   closes	   the	   circuit,	  
otherwise	   the	   circuit	   remains	   open.	   The	   solid-­‐state	   relay	   is	   connected	   to	   the	  
Measurement	  Computing	  1208FS	  A/D	  converter	  output	   voltage	   channels.	   Channel	  
12	   serves	   as	   the	   ground	   and	   channel	   13	   distributes	   the	   voltage.	   A	   LabVIEW	  
algorithm	  streams	  continuous	  voltage	  out	  of	  the	  A/D	  converter.	  While	  the	  program	  
is	  running	  the	  voltage	  can	  be	  controlled.	  	  If	  no	  stimulus	  is	  needed,	  0V	  is	  sent	  out	  of	  
the	   A/D	   converter	   and	   the	   solid-­‐state	   relay	   remains	   open	   and	   no	   stimulus	   is	  
activated	  as	  seen	  below	  in	  Figure	  5.	  If	  the	  stimulus	  needs	  to	  be	  activated,	  4V	  is	  sent	  
to	   the	   solid-­‐state	   relay,	   the	   circuit	   closes,	   and	   the	   batteries	   power	   the	   vibrating	  
disks.	  This	  is	  shown	  below	  in	  Figure	  6.	  
	  
Fig	  5.	  Open	  Stimulus	  Circuit	  When	  no	  stimulus	  is	  necessary	  zero	  volts	  are	  supplied	  
to	  the	  solid-­‐state	  relay	  and	  the	  circuit	  remains	  open.	  
	  
	  
Fig	  6.	  Closed	  Stimulus	  Circuit	  When	  a	  stimulus	  is	  necessary	  four	  volts	  are	  supplied	  
to	  the	  solid-­‐state	  relay	  and	  the	  circuit	  closes.	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The	  final	  component	  of	  this	  prototype	  is	  the	  audible	  alert	  mechanism.	  This	  is	  
built	   in	   to	   the	   system	   as	   a	   safety	   net.	   If	   the	   stimulus	   is	   unsuccessful	   in	   restoring	  
natural	  biosignals,	  then	  the	  audible	  alert	  will	  awake	  the	  caregiver	  to	  intervene.	  For	  
this	  prototype	  the	  audible	  alert	  is	  the	  Microsoft	  Windows	  “beep”.	  This	  alert	  is	  based	  
on	   the	   amount	   of	   time	   that	   the	   stimulus	   is	   continuously	   activated.	  As	   soon	   as	   the	  
stimulus	   is	   triggered	  a	   clock	  starts.	   If	   the	   stimulus	  goes	  off	  before	   the	  safety	   time,	  
then	  the	  clock	  resets	  to	  zero.	  If	  the	  stimulus	  was	  active	  for	  a	  period	  greater	  than	  or	  
equal	   to	   the	   safety	   time,	   then	   the	   LabVIEW	   algorithm	   continuously	   calls	   the	  
Windows	   “beep”	   until	   the	   program	   is	   stopped.	   The	   safety	   time	   is	   a	   control;	   for	  
demonstration	  purposes	  it	  was	  set	  to	  10	  seconds.	  	  
Integration	   of	   the	   four	   components	   was	   fairly	   simple.	   The	   final	   system	  
worked	   effectively.	   Both	   signals	   successfully	   streamed	   together	   without	  
interference.	  The	   threshold	  analysis	  was	  based	  on	  an	   “or”	  comparison	  such	   that	   if	  
the	   respiratory	   “or”	   oxygen	   saturation	   thresholds	  were	  met,	   the	   voltage	  was	   sent	  
out	  the	  A/D	  converter.	  The	  stimulus	  activated	  only	  when	  necessary	  and	  turned	  off	  if	  
normal	  biosignals	  were	  restored.	  If	  the	  stimulus	  was	  active	  for	  a	  period	  greater	  than	  
or	   equal	   to	   the	   safety	   time	   the	   alert	  mechanism	  was	   coded	   to	   activate.	   The	   alert	  
mechanism	  successfully	  triggered	  in	  the	  separate	  applications	  but	  for	  an	  unknown	  
reason,	   when	   the	   two	   biosignals	   were	   integrated,	   the	   alert	   mechanism	   failed	   to	  
sound.	  	  
The	   integrated	   system	   has	   a	   graphic	   user	   interface	   (GUI)	   that	   is	   easy	   to	  
navigate.	  For	  the	  respiratory	  aspects,	  the	  GUI	  consists	  of	  two	  waveform	  generators	  
depicting	   the	   unfiltered	   and	   filtered	   respiratory	   signal.	   The	   cutoff	   frequency	   is	   a	  
control	   on	   the	   GUI.	   The	   pulse	   oximeter	   aspects	   consist	   of	   a	  window	   that	   streams	  
both	  oxygen	  saturation	  and	  heart	  rate	  data.	  Also	  the	  array	  that	  is	  built	  to	  obtain	  the	  
reference	   saturation	   is	   visible,	   and	   the	   user	   can	   watch	   as	   the	   array	   fills	   to	   the	  
desired	  size.	  In	  the	  GUI	  the	  user	  can	  control	  all	  necessary	  variables,	  and	  observe	  all	  
changing	  parameters.	  The	  clocks	  are	  all	  displayed	  in	  the	  GUI	  as	  well,	  so	  that	  anyone	  
can	  easily	  understand	  when	  and	  what	  is	  being	  triggered.	  The	  separate	  components	  
of	  the	  GUI	  are	  displayed	  below.	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Fig.	  7	  Channels	  and	  Pulse	  Oximeter	  The	  channels	  for	  sending	  voltage	  in	  and	  out	  of	  
the	  A/D	  converter	  can	  be	  controlled	  on	  the	  left,	  and	  the	  array	  for	  determining	  the	  
reference	  saturation	  is	  displayed	  on	  the	  right.	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Fig.	  8	  Pulse	  Oximeter	  Display	  Window	  Both	  the	  oxygen	  saturation	  and	  the	  heart	  
rate	  are	  continuously	  displayed	  in	  this	  window.	  The	  settings	  for	  the	  serial	  data	  
streaming	  from	  the	  pulse	  oximeter	  are	  displayed	  here	  as	  well.	  
	  
	  
Fig.	  9	  Respiratory	  Waveform	  Generators	  and	  Controls	  The	  raw	  respiratory	  
signal	  is	  continuously	  displayed	  on	  top	  while	  the	  respective	  filtered	  respiratory	  
signal	  is	  displayed	  below.	  The	  controls	  for	  the	  filter	  and	  timer	  are	  to	  the	  left	  of	  the	  
waveform	  generators.	  	  
	  
Design	  Evaluation	  
	   As	   described	   in	   the	   previous	   sections,	   a	   functional	   prototype	   has	   been	  
constructed	   that	   monitors	   breathing	   rate	   and	   can	   generate	   a	   stimulus	   to	   return	  
breathing	   to	   normal	   patterns.	   In	   regards	   to	   actually	   constructing	   the	   prototype,	  
there	   were	   various	   tests	   that	   were	   performed.	   Two	   of	   the	   tests	   involved	  making	  
sure	   the	  voltage	   relay	  was	  being	   triggered	  correctly.	  There	  were	   two	  methods	   for	  
triggering	   the	   relay:	   pulse	   oximeter	   trigger	   and	  RIP	   belt	   trigger.	   A	   LabVIEW	   code	  
was	   constructed	   that	  monitored	   the	   blood	   oxygen	   saturation	   levels	   continuously.	  
Once	  the	  oxygen	  dropped	  to	  a	  preset	  level,	  the	  relay	  was	  triggered.	  In	  order	  to	  test	  
that	   the	   relay	   was	   triggered	   a	   voltmeter	   was	   connected	   to	   the	   A/D	   converter	   to	  
ensure	  that	  the	  minimum	  voltage	  (4V)	  was	  being	  produced.	  The	  same	  method	  was	  
employed	  for	  the	  RIP	  belt	  trigger.	  Once	  a	  cessation	  in	  breathing	  was	  recognized	  by	  
the	   code,	   the	   A/D	   converter	   was	   triggered	   to	   release	   a	   voltage	   to	   trigger	   the	  
connected	   relay.	   Again,	   a	   voltmeter	  was	   used	   to	   ensure	   that	   the	   requisite	   voltage	  
was	  being	  produced.	  There	  were	  also	  two	  other	  tests	  that	  were	  performed	  involving	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the	  pulse	  oximeter	  and	  RIP	  belt:	   triggering	   the	  alarm	  with	   these	   two	  devices.	  This	  
was	   tested	   by	   simply	  making	   sure	   that	   the	   alarm	  went	   off	   after	   a	   specified	   time.	  
Again,	   this	   alarm	   was	   controlled	   by	   a	   Labview	   code.	   Once	   all	   the	   individual	  
components	  were	   tested	   to	   ensure	   that	   they	   triggered	   the	   vibration	   stimulus	   and	  
alarm,	   the	   components	  were	   combined	   into	   one	   device.	   As	   previously	  mentioned,	  
when	  fully	  integrated	  the	  vibrating	  stimulus	  acted	  as	  expected	  but	  the	  audible	  alert	  
mechanism	   did	   not	   sound.	   It	   is	   still	   unknown	   why	   the	   alarm	   did	   not	   function	  
properly	  with	  the	  two	  biosignals	  acting	  together.	  	  
	   It	  should	  be	  noted	  that	  there	  were	  other	  tests	  that	  need	  to	  be	  performed	  to	  
further	  validate	  the	  efficacy	  of	  the	  proposed	  prototype	  to	  effectively	  monitor	  apnea	  
episodes	   and	   provide	   stimuli	   to	   interrupt	   such	   episodes.	   The	   most	   obvious	   test	  
would	  be	  to	  have	  someone,	  without	  apnea,	  sleep	  with	  the	  device	  on	  and	  see	  if	  they	  
could	  be	  woken	  by	  the	  vibrating	  motors.	  This	  was	  not	  able	  to	  be	  accomplished	  for	  a	  
variety	  of	  reasons.	  One	  reason	  was	  that,	  the	  current	  prototype	  is	  not	  easily	  portable	  
and	  is	  located	  in	  a	  research	  lab	  on	  campus.	  This	  would	  involve	  someone	  sleeping	  in	  
a	   lab	   for	   a	   prolonged	   period	   of	   time,	   which	   is	   simply	   not	   realistic	   in	   the	   current	  
location	  of	  the	  device.	  Another	  reason	  that	  this	  test	  was	  not	  performed	  is	  centered	  
around	   legal	   issues	   concerning	   human	   testing.	   It	   is	   very	   hard	   to	   test	   any	  medical	  
device	   on	   humans	  without	   proper	   paper	  work	   and	   prior	   approval	   from	   the	   FDA.	  
Since	   legal	   considerations	   should	   always	   be	   taken	   into	   account	   with	   any	  
development	  of	  a	  novel	  device,	  we	  believed	   it	  was	   in	  our	  and	  the	  university’s	  best	  
interest	  to	  not	  conduct	  such	  testing.	  In	  addition	  to	  stimulus	  response	  testing,	  apnea	  
monitoring	  testing	  would	  also	  be	  a	  test	  that	  needs	  to	  happen	  to	  ensure	  the	  viability	  
of	   the	   proposed	   device.	   Again,	   such	   human	   testing	   would	   require	   extensive	  
paperwork	   and	   actually	   someone	  with	   apnea,	   both	   of	   which	  were	   not	   able	   to	   be	  
obtained.	  	  
	   As	  with	   any	   new	  device,	   one	   of	   the	   principle	   limiting	   factors	   to	   continuing	  
production	  to	  a	  marketable,	  complete	  product	   is	   the	  price	   to	  produce	  each	  device.	  
After	   careful	   review	   of	   invoices	   and	   receipts,	   it	  was	   determined	   that	   some	   of	   the	  
expenditures	  would	  not	  need	  to	  be	  included	  in	  the	  final	  expected	  cost	  of	  prototype	  
reproduction.	  Excluding	  a	  LabVIEW	  software	  license,	  reproducing	  this	  prototype	  of	  
an	   automated	   home	   apnea	   system	   would	   cost	   approximately	   $1150.00.	   The	  
breakdown	  of	  these	  expected	  costs	  can	  be	  found	  in	  Appendix	  A.	   It	  should	  be	  noted,	  
that	  actual	  production	  costs	  would	  be	  considerably	  less	  due	  to	  buying	  the	  necessary	  
components	  in	  bulk	  and	  at	  a	  wholesale	  price.	  	  
	   In	  evaluation	  of	  the	  final	  constructed	  prototype,	   it	  can	  be	  confidently	  stated	  
that	   a	   minimally	   viable	   product	   has	   been	   constructed	   to	   participate	   in	   the	   first	  
stages	  of	  beta	  testing.	  This	  concept	  of	  a	  minimally	  viable	  product	  is	  the	  new	  normal	  
in	  terms	  of	  product	  development.	  The	  thought	  process	  behind	  this	  is	  a	  development	  
group	   quickly	   builds	   a	   functional	   prototype	   that	   is	   far	   from	   complete,	   in	   order	   to	  
adapt	  to	  the	  markets	  wants	  and	  needs	  in	  an	  efficient	  manner.	  Once	  this	  prototype	  is	  
being	   tested,	   consumer	   surveys	   can	   be	   given	   routinely	   in	   order	   to	   constantly	  
improve	  the	  product	  while	  still	  building	  traction	  in	  the	  market	  (see	  The	  Lean	  Startup	  
by	  Eric	  Reis).	  The	  automated	  home	  apnea	  system	  is	  on	  the	  precipice	  of	  beta	  testing	  
and	  can	  be	  considered	  a	  minimally	  viable	  product.	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Recommendations	  and	  Future	  Work	  
	   As	  with	  any	  prototype	  development,	  there	  is	  a	  multitude	  of	  things	  to	  be	  done	  
in	  the	  future	  to	  ensure	  that	  this	  product	  makes	  it	  to	  market	  and	  can	  be	  considered	  
financially	  viable.	  However,	  there	  are	  certain	  aspects	  of	  this	  device	  that	  already	  give	  
it	  competitive	  advantages	  over	  existing	  products.	  This	  prototype	  is	  the	  only	  device	  
available	  that	  is	  marketed	  explicitly	  for	  home	  use.	  Other	  existing	  monitoring	  devices	  
for	  infants	  are	  specifically	  designed	  for	  clinical	  use	  and	  cannot	  be	  incorporated	  for	  
home	   use.	   Devices	   that	   currently	   exist	   for	   home	   use	   do	   not	   possess	   the	   accurate	  
measurement	  capabilities	  of	   the	  one	   that	   is	  proposed	   in	   this	  report.	   In	  addition	   to	  
this,	  the	  proposed	  device	  is	  the	  only	  known	  device	  that	  incorporates	  monitoring	  and	  
stimulation	  into	  one	  combined	  device.	  Although	  the	  functionalities	  of	  this	  device	  do	  
not	   currently	   exist	   in	   a	   home	   market,	   the	   price	   of	   reproduction	   would	   be	   a	  
significant	   limiting	   factor	   to	   wide	   spread	   adoption	   and	   sustained	   revenue	  
generation.	  Any	  devices	  that	  cost	  more	  than	  a	  thousand	  dollars	  severely	   limits	  the	  
accessible	  markets;	  significant	  reduction	  in	  price	  would	  have	  to	  be	  achieved	  to	  bring	  
this	  product	  to	  market	  and	  generate	  significant	  revenue.	  	  
	   The	   future	   development	   of	   this	   device	   consists	   of	   a	   variety	   of	   actions.	   The	  
main	   aspect	   that	   needs	   to	   be	   addressed	   is	   testing	   on	   subjects	  who	   actually	   suffer	  
from	  apnea,	  and	   then	  progressing	   to	   infants	   that	  suffer	   from	  apnea.	  As	  mentioned	  
earlier,	   there	   is	   extensive	   documentation	   and	   FDA	   approval	   required	   for	   such	  
testing.	   In	  addition	   to	   testing	   there	  are	  some	  hardware	  related	  components	  of	   the	  
device	   that	   need	   to	   be	   addressed	   in	   the	   future	   development	   of	   the	   product.	   The	  
major	   area	   that	   needs	   addressing	   is	   to	   consolidate	   the	   device	   down	   into	   an	  
extremely	  portable,	  compact	  system.	  At	  its	  current	  status,	  a	  computer	  is	  needed	  for	  
the	  device	  to	  function.	  Theoretically	  everything	  that	  the	  computer	  does	  can	  be	  hard	  
coded	   onto	   a	   chip	   and	   be	   contained	   on	   the	   device	   itself.	   Ideally	   the	   final,	  market	  
ready	   design	   would	   consist	   of	   just	   a	   belt	   that	   is	   placed	   on	   the	   patient	   that	  
simultaneously	  monitors	  breathing,	  blood	  oxygen	  (via	  reflective	  pulse	  oximetry	  on	  
the	  chest),	  emits	  a	  stimulus	  (via	  vibrating	  disks	  embedded	  in	  the	  belt),	  and	  alerts	  the	  
caretaker	  of	  any	  prolonged	  apnea	  episodes	  (via	  an	  alarm	  that	  is	  sent	  to	  a	  phone	  or	  
other	   device).	   Complete	   development	   of	   a	  market	   ready	  device	  would	  most	   likely	  
take	   at	   least	   two	   years	   of	   continuous	   work.	   Also	   increasing	   the	   size	   of	   the	  
development	   team	   would	   be	   required	   to	   ensure	   that	   this	   product	   can	   be	   fully	  
completed.	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Appendix	  A	  
	  
Manufacturing Bill of Materials 
Item Description Vendor Quantity Price per 
product* 






































8. NONIN 8500 Hand 
Held Pulse 
Oximeter 
Turner Medical 1 $325.00 
9. NONIN 1000 USB 
Download Cable 
Turner Medical 1 $90.00 
13. Vibrating Disk 
Motor 
RobotShop 10 $3.40 
14. 9 Volt Battery Walgreens 1 $3.00 
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 NTE Electronics 
Solid-State Relay 
Shield’s 
Electronics 
1 $75.00 
 
 
	  
